RacGAP1 overexpression partially reduced the cytotoxicity caused by CGN with or without IR treatment (Figure 5E), which suggests that RacGAP1 is indeed an important molecular target in CGN treatment. This evidence concerns the gene RACGAP1 and childhood gender nonconformity.